Table 3 OAB symptom severity score and OAB-q HRQoL score.

From: Efficacy of the combination of transcutaneous tibial nerve stimulation and mirabegron in women with overactive bladder in a prospective randomized controlled trial

Variables, mean ± SD or n (%)

Mirabegron group (n = 20)

Combination group (n = 20)

P-value

OAB symptom severity score

 Baseline

31.25 ± 14.51

34.37 ± 16.87

0.075

 6 weeks

26.81 ± 7.33

20.87 ± 8.74

< 0.001

 3 months

23.37 ± 5.68

13.14 ± 4.23

< 0.001

OAB-q HRQoL score

 Baseline

28.51 ± 12.67

35.34 ± 16.67

0.085

 6 weeks

38.39 ± 11.38

64.39 ± 14.19

< 0.001

 3 months

37.66 ± 10.15

66.37 ± 12.83

< 0.001

  1. OAB-q overactive bladder questionnaire, HRQol health-related quality of life.P < 0.05 is considered statistically significant.
Back to article page